Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2015 07:05 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma's MAT9001 Demonstrates Superiority in Reducing Triglycerides, Lipids, Apolipoproteins and PCSK9 Levels in Head-to-Head Study With Vascepa(R)

BEDMINSTER, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company, announced the presentation of data from a head-to-head...
June 15, 2015 07:05 ET | Source: Amarantus BioScience Holdings, Inc.

Amarantus Announces Presentation of Eltoprazine Phase 1/2a Clinical Data at the 19th International Congress of Parkinson's Disease and Movement Disorders

SAN FRANCISCO and GENEVA, June 15, 2015 (GLOBE NEWSWIRE) -- Amarantus BioScience Holdings, Inc. (OTCQB:AMBSD), a biotechnology company focused on developing therapeutic and diagnostic products for...
June 15, 2015 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Data at the European Hematology Association 20th Congress

GALE-401 was well tolerated with primarily Grade 1 and 2 toxicities Phase 2 pilot study demonstrated an Overall Response Rate of 78% PORTLAND, Ore., June 15, 2015 (GLOBE NEWSWIRE) --...
June 15, 2015 07:03 ET | Source: APO (African Press Organization)

The International Public Relations Association (IPRA) Makes APO the Official Newswire of IPRA Public Relations World Congress

JOHANNESBURG, South-Africa, June 15, 2015 (GLOBE NEWSWIRE) -- The International Public Relations Association (IPRA) (http://www.ipra.org), the world's most influential professional association for...
June 15, 2015 07:03 ET | Source: PlasmaTech Biopharmaceuticals

PlasmaTech Biopharmaceuticals Expands Rare Disease Pipeline With License Agreement for Gene Therapy in Fanconi Anemia & CRISPR/Cas9-Based Technology Platform for Rare Blood Disorders

NEW YORK, NY and CLEVELAND, OH--(Marketwired - June 15, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI)CRISPR-Cas9 Gene-Editing System Demonstrated Promising Efficacy in Repairing the FANCC...
June 15, 2015 07:01 ET | Source: AxoGen, Inc.

AxoGen, Inc. To Host First International Surgeon Training Course and Announces Presentation of New Clinical Data at European Hand Meeting

ALACHUA, Fla., June 15, 2015 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on restoring quality of life through nerve repair, today...
June 15, 2015 07:01 ET | Source: ExtraHop Networks

ExtraHop Shines a Light Into AWS Performance for Conga

ORLANDO, FL--(Marketwired - Jun 15, 2015) - Gartner IT Operations Strategies & Solutions Summit - ExtraHop, the global leader in real-time wire data analytics for IT operational intelligence,...
June 15, 2015 07:00 ET | Source: STT Enviro Corp.

STT Enviro Corp. Announces Full Repayment of Outstanding Term Debt

TORONTO, ON--(Marketwired - June 15, 2015) - STT Enviro Corp. ("STT" or the "Company") (TSX VENTURE: STT) announced today that it has repaid the final $1,022,959 of its outstanding term debt. The...
June 15, 2015 07:00 ET | Source: ENSERVCO

ENSERVCO to Present at GHS 100 Energy Conference

DENVER, CO--(Marketwired - Jun 15, 2015) - ENSERVCO Corporation (NYSE MKT: ENSV), a diversified national provider of well-site services to the domestic onshore conventional and unconventional oil...
June 15, 2015 07:00 ET | Source: Northern Empire Resources Corp.

Northern Empire and Sonoro Complete Phase 1 Hilltop Exploration Program

VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 15, 2015) - Northern Empire Resources Corp. (TSX VENTURE:NM) ("Northern Empire"), along with Sonoro Metals Corp. ("Sonoro"), today...

1 ...215629 215630 215631 ...326018